U.S. RESEARCH ROUNDUP- Boeing, Intel, Silvergate Capital

Clover Health Investments

21/11/2022 07:26

Nov 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Boeing, Intel, and Silvergate Capital on Monday. 
    HIGHLIGHTS
                 * Boeing  BA.N : Jefferies raises target price to $200 from $180
 
                 * Intel Corp  INTC.O : Cowen and Company reinstates coverage with market
 perform
 
                 * Silvergate Capital Corp  SI.N : Wells Fargo raises to equal weight from
 underweight
 
 Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock
entries are in alphabetical order. 
                 * 9 Meters Biopharma Inc  NMTR.O : Truist Securities cuts target price to $38 from
 $40
 
                 * Ambarella Inc  AMBA.O : Jefferies cuts target price to $96 from $104
 
                 * Atkore Inc  ATKR.N : RBC raises target price to $136 from $110
 
                 * Autodesk Inc  ADSK.O : RBC raises target price to $260 from $257
 
                 * Boeing  BA.N : Jefferies raises target price to $200 from $180
 
                 * Brightview Holdings Inc  BV.N : Jefferies assumes coverage with hold rating vs
 buy rating
 
                 * Brightview Holdings Inc  BV.N : Jefferies assumes coverage with target price $8
 vs $14
 
                 * Cingulate Inc  CING.O : Ascendiant Capital Markets cuts target price to $6.50
 from $7
 
                 * Clover Health Investments Corp  CLOV.O : Credit Suisse cuts target price to
 $2.50 from $3
 
                 * Consensus Cloud Solutions Inc  CCSI.O : JP Morgan starts with neutral rating; PT
 $54
 
                 * Dolby Laboratories Inc  DLB.N : Barrington Research cuts to market perform
 
                 * Finance of America Companies Inc  FOA.N : Credit Suisse cuts target price to
 $3.50 from $4
 
                 * Foot Locker Inc  FL.N : Telsey Advisory Group raises target price to $39 from
 $37
 
                 * Foot Locker Inc  FL.N : Wedbush raises target price to $37 from $30
 
                 * Goodrx Holdings Inc  GDRX.O : Credit Suisse cuts target price to $9 from $11
 
                 * Griffon Corp  GFF.N : Stephens raises target price to $45 from $40
 
                 * H.B. Fuller Company  FUL.N : JP Morgan raises target price to $70 from $52
 
                 * Home Point Capital Inc  HMPT.O : Credit Suisse cuts target price to $3.50 from
 $4
 
                 * Intel Corp  INTC.O : Cowen and Company reinstates coverage with market perform
 
                 * Intel Corp  INTC.O : Cowen and Company reinstates coverage with target price $31
 
                 * Iovance Biotherapeutics Inc  IOVA.O : Chardan Capital Markets cuts PT to $29
 from $30
 
                 * Iovance Biotherapeutics Inc  IOVA.O : Oppenheimer cuts target price to $25 from
 $27
 
                 * Iovance Biotherapeutics Inc  IOVA.O : Piper Sandler cuts target price to $11
 from $13
 
                 * Iovance Biotherapeutics Inc  IOVA.O : Truist Securities cuts target price to $16
 from $18
 
                 * Kaman Corp  KAMN.N : JP Morgan cuts target price to $21 from $37
 
                 * Loandepot Inc  LDI.N : Credit Suisse cuts target price to $2.50 from $3.25
 
                 * Moderna Inc  MRNA.O : JP Morgan raises target price to $132 from $120
 
                 * Modiv Inc  MDV.N : Colliers Securities cuts target price to $15
 
                 * Nevro Corp  NVRO.N : Truist Securities raises target price to $45 from $41
 
                 * Oscar Health Inc  OSCR.N : Credit Suisse cuts target price to $7 from $8
 
                 * P&G  PG.N : Raymond James raises target price to $165 from $155
 
                 * PayPal Holdings Inc  PYPL.O : Jefferies raises target price to $90 from $75
 
                 * Pennantpark Investment Corp  PNNT.N : JP Morgan cuts target price to $6 from
 $6.50
 
                 * Presidio Property Trust Inc  SQFT.O : Colliers Securities cuts to neutral from
 buy
 
                 * Presidio Property Trust Inc  SQFT.O : Colliers Securities cuts PT to $1.50 from
 $3.75
 
                 * Provention Bio Inc  PRVB.O : Chardan Capital Markets raises target price to $30
 from $24
 
                 * Provention Bio Inc  PRVB.O : SVB Securities raises target price to $19 from $16
 
                 * Salesforce Inc  CRM.N : Jefferies cuts target price to $240 from $250
 
                 * Silvergate Capital Corp  SI.N : Wells Fargo raises to equal weight from
 underweight
 
                 * Silvergate Capital Corp  SI.N : Wells Fargo raises target price to $30 from $25
 
                 * Sitio Royalties Corp  STR.N : Jonestrading raises target price to $37
 
                 * Snowflake Inc.  SNOW.N : Jefferies cuts target price to $200 from $220
 
                 * Splunk Inc  SPLK.O : Jefferies cuts target price to $100 from $130
 
                 * Surgepays Inc  SURG.O : Ascendiant Capital Markets raises target price to $9
 from $8.75
 
                 * Targa Resources Corp  TRGP.N : JP Morgan raises target price to $111 from $108
 
                 * Tattooed Chef Inc  TTCF.O : Cowen and Company cuts target price to $2 from $4.50
 
                 * Twist Bioscience Corp  TWST.O : Evercore ISI cuts target price to $28 from $40
 
                 * Twist Bioscience Corp  TWST.O : JP Morgan cuts target price to $24 from $35
 
                 * Twist Bioscience Corp  TWST.O : SVB Securities cuts target price to $30 from $45
 
                 * Verastem Inc  VSTM.O : Truist Securities cuts target price to $5 from $6
 
                 * Verb Technology Company Inc  VERB.O : Ascendiant Capital Markets cuts PT to $3
 from $4.25
 
                 * Williams-Sonoma Inc  WSM.N : Evercore ISI cuts target price to $125 from $130
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))